Back

Association of preoperative NT-proBNP with 30-day and five-year mortality after cardiac surgery

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diagnostic accuracy of natriuretic peptides Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Fabian Theurl

Innsbruck (Austria)

8 More presentations in this session

Presentation thumbnail
ESC Heart Failure Association age-adjusted natriuretic peptide thresholds for a new diagnosis of heart failure: diagnostic accuracy study
Professor C. Taylor (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Screening for stage B heart failure in Type 2 diabetes: natriuretic peptide screening alone misses echocardiographic abnormalities
Doctor C. Chandramouli (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical diabetic cardiomyopathy
Doctor P. Gouda (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Exploring heart failure prevalence and overlooked dimensions: a comprehensive NT Pro-BNP study in high-risk primary care patients
Professor A. Celik (Mersin, TR)
Abstract Slides Video
Presentation thumbnail
Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
Doctor Y. Takigami (Sagamihara, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnostic accuracy of natriuretic peptides

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of natriuretic peptide value in patients with symptomatic and asymptomatic severe aortic stenosis
thumbnail
Congress Presentation
Mid-regional pro-adrenomedullin is an independent predictor of cardiovascular outcomes in cardiac surgery, a prospective cohort study in 500 patients
thumbnail
Congress Presentation
Subgroup-specific target of nt-probnp level in heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources